As of January 2025, Medifron DBT has a market cap of $45.09M. This makes Medifron DBT the world's 23832th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $51.45M | 47.51% |
2023 | $34.88M | -14.52% |
2022 | $40.80M | -55.51% |
2021 | $91.72M | -65.11% |
2018 | $262.91M | 36.21% |
2017 | $193.01M | 26.27% |
2016 | $152.86M | 27.59% |
2015 | $119.81M | 37.82% |
2014 | $86.93M | -19.20% |
2013 | $107.58M | -14.85% |
2012 | $126.35M | - |